MACCARRONE, MAURO
 Distribuzione geografica
Continente #
NA - Nord America 20.344
EU - Europa 1.575
AS - Asia 370
Continente sconosciuto - Info sul continente non disponibili 11
SA - Sud America 11
OC - Oceania 7
AF - Africa 3
Totale 22.321
Nazione #
US - Stati Uniti d'America 20.331
UA - Ucraina 275
DE - Germania 247
IE - Irlanda 216
CN - Cina 211
IT - Italia 149
FR - Francia 146
SE - Svezia 133
KR - Corea 108
PL - Polonia 104
GB - Regno Unito 94
NL - Olanda 71
FI - Finlandia 63
RU - Federazione Russa 47
EU - Europa 10
KG - Kirghizistan 10
BE - Belgio 7
JP - Giappone 7
AU - Australia 6
CA - Canada 6
SG - Singapore 6
BR - Brasile 5
IR - Iran 5
CL - Cile 4
DK - Danimarca 4
DM - Dominica 4
IL - Israele 4
IN - India 4
RS - Serbia 4
VN - Vietnam 4
CH - Svizzera 3
LT - Lituania 3
MX - Messico 3
ES - Italia 2
NO - Norvegia 2
RO - Romania 2
TW - Taiwan 2
UZ - Uzbekistan 2
ZA - Sudafrica 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BG - Bulgaria 1
CO - Colombia 1
ET - Etiopia 1
GR - Grecia 1
HK - Hong Kong 1
IQ - Iraq 1
KW - Kuwait 1
LK - Sri Lanka 1
MK - Macedonia 1
NZ - Nuova Zelanda 1
PE - Perù 1
QA - Qatar 1
TH - Thailandia 1
TR - Turchia 1
Totale 22.321
Città #
Woodbridge 5.906
Wilmington 5.610
Houston 4.885
Fairfield 815
Ann Arbor 548
Chandler 397
Ashburn 308
Seattle 298
Cambridge 254
Jacksonville 242
Dublin 207
Medford 161
Beijing 115
Kraków 101
Lawrence 76
New York 72
Dearborn 64
Rome 43
Mülheim 37
San Diego 34
Menlo Park 31
Zhengzhou 29
Redwood City 17
Norwalk 16
San Mateo 16
Saint Petersburg 15
University Park 15
Falls Church 14
Mountain View 14
London 12
Milan 12
Kunming 11
Nanjing 10
Palo Alto 10
Bari 9
Helsinki 8
Nürnberg 8
Verona 8
Brussels 7
Detroit 6
Hefei 6
Shanghai 6
Berlin 5
Boardman 5
Guangzhou 5
Mcallen 5
San Francisco 5
Seoul 5
Chicago 4
Hounslow 4
Jinan 4
Redmond 4
Roseau 4
São Paulo 4
Toronto 4
Clearwater 3
Del Norte 3
Dong Ket 3
Fremont 3
Garden City 3
Hanover 3
Lappeenranta 3
Montague 3
Nashville 3
Rodigo 3
Royal Oak 3
Turin 3
Agliana 2
Alderley Edge 2
Auburn Hills 2
Belgrade 2
Buffalo 2
Carate Brianza 2
Cesano Maderno 2
Chongqing 2
Council Bluffs 2
Fars 2
Frederiksberg 2
Fuzhou 2
Giv‘atayim 2
Head of Westport 2
Hebei 2
Islington 2
Kilburn 2
Liverpool 2
Los Angeles 2
Mexico City 2
Nanchang 2
New Bedfont 2
Philadelphia 2
Pune 2
Salt Lake City 2
Secaucus 2
Southwark 2
Tokyo 2
Wandsworth 2
Waverly 2
Yreka 2
Acton 1
Adelaide 1
Totale 20.611
Nome #
Cannabinoids therapeutic use: what is our current understanding following the introduction of THC, THC:CBD oromucosal spray and others? 486
Abnormal mGlu 5 receptor/endocannabinoid coupling in mice lacking FMRP and BC1 RNA 442
Downstream effects of endocannabinoid on blood cells: Implications for health and disease 437
Cerebrospinal fluid levels of the endocannabinoid anandamide are reduced in patients with untreated newly diagnosed temporal lobe epilepsy. 430
Distinct modulation of human myeloid and plasmacytoid dendritic cells by anandamide in multiple sclerosis 425
Type-1 cannabinoid receptors colocalize with caveolin-1 in neuronal cells 418
High endogenous cannabinoid levels in the cerebrospinal fluid of untreated Parkinson's disease patients 417
Modulation of monocytes by bioactive lipid anandamide in multiple sclerosis involves distinct Toll-like receptors 416
Chronic cocaine sensitizes striatal GABAergic synapses to the stimulation of cannabinoid CB1 receptors 414
The (endo)cannabinoid system in multiple sclerosis and amyotrophic lateral sclerosis 414
Abnormal sensitivity to cannabinoid receptor stimulation might contribute to altered gamma-aminobutyric acid transmission in the striatum of R6/2 Huntington's disease mice 410
Age-related changes of anandamide metabolism in CB1 cannabinoid receptor knockout mice: correlation with behaviour 409
Interaction between interleukin-1β and type-1 cannabinoid receptor is involved in anxiety-like behavior in experimental autoimmune encephalomyelitis 408
The (AAT)n repeat of the cannabinoid CB1 receptor gene influences disease progression in relapsing multiple sclerosis. 407
Lack of effect of cannabis-based treatment on clinical and laboratory measures in multiple sclerosis 407
TRPV1 channels facilitate glutamate transmission in the striatum 402
Abnormal sensitivity of cannabinoid CB1 receptors in the striatum of mice with experimental amyotrophic lateral sclerosis 401
The brain cytoplasmic RNA BC1 regulates dopamine D2 receptor-mediated transmission in the striatum 399
Effects of palmitoylation of Cys(415) in helix 8 of the CB(1) cannabinoid receptor on membrane localization and signalling 396
Trans-crocetin improves amyloid-β degradation in monocytes from Alzheimer's Disease patients 396
Urinary N-acetyl-beta-D-glucosaminidase concentration in patients with spinal cord injury: relationship with urodynamic parameters 395
Subventricular zone neural progenitors protect striatal neurons from glutamatergic excitotoxicity 393
null 393
Brain-derived neurotrophic factor controls cannabinoid CB1 receptor function in the striatum 392
TRPV1 channels regulate cortical excitability in humans 391
Preservation of striatal cannabinoid CB1 receptor function correlates with the antianxiety effects of fatty acid amide hydrolase inhibition 386
Transient receptor potential vanilloid 1 channels modulate the synaptic effects of TNF-α and of IL-1β in experimental autoimmune encephalomyelitis 382
The endocannabinoid system in peripheral lymphocytes as a mirror of neuroinflammatory diseases 377
Comment on "Cannabinoid receptor and N-acyl phosphatidylethanolamine phospholipase D--evidence for altered expression in multiple sclerosis" 376
Dopamine-dependent CB1 receptor dysfunction at corticostriatal synapses in homozygous PINK1 knockout mice 375
Structure-to-function relationship of mini-lipoxygenase, a 60-kDa fragment of soybean lipoxygenase-1 with lower stability but higher enzymatic activity 372
Cannabinoid CB1 receptors regulate neuronal TNF-α effects in experimental autoimmune encephalomyelitis 371
Experimental parkinsonism alters endocannabinoid degradation: implications for striatal glutamatergic transmission 367
Interleukin-1β Causes Anxiety by Interacting with the Endocannabinoid System 366
HIV-1 coat glycoprotein gp120 induces apoptosis in rat brain neocortex by deranging the arachidonate cascade in favor of prostanoids 364
The endocannabinoid pathway in Huntington's disease: a comparison with other neurodegenerative diseases 363
The endocannabinoid system in targeting inflammatory neurodegenerative diseases 361
Endocannabinoids limit metabotropic glutamate 5 receptor-mediated synaptic inhibition of striatal principal neurons 361
Pre- and postsynaptic type-1 cannabinoid receptors control the alterations of glutamate transmission in experimental autoimmune encephalomyelitis 361
A critical interaction between dopamine D2 receptors and endocannabinoids mediates the effects of cocaine on striatal gabaergic Transmission 356
Levodopa treatment reverses endocannabinoid system abnormalities in experimental parkinsonism 352
The endocannabinoid system and its therapeutic exploitation in multiple sclerosis: Clues for other neuroinflammatory diseases 350
GADD153 and 12-lipoxygenase mediate fenretinide-induced apoptosis of neuroblastoma 349
Type-1 (CB1) cannabinoid receptor promotes neuronal differentiation and maturation of neural stem cells . 348
Stimulation of autophagy by rapamycin protects neurons from remote degeneration after acute focal brain damage 346
Exploitation of the HIV-1 coat glycoprotein, gp120, in neurodegenerative studies in vivo 343
Altered anandamide degradation in attention-deficit/hyperactivity disorder 339
Lipid rafts regulate 2-arachidonoylglycerol metabolism and physiological activity in the striatum 329
In vitro and in vivo models of Huntington's disease show alterations in the endocannabinoid system 328
Cannabinoid receptor signaling in neurodegenerative diseases: a potential role for membrane fluidity disturbance 327
Association between a genetic variant of type-1 cannabinoid receptor and inflammatory neurodegeneration in multiple sclerosis 322
Functional characterization of putative cholesterol binding sequence (CRAC) in human type-1 cannabinoid receptor 321
TRPV1 channels regulate cortical excitability in humans 258
Potential for diagnosis versus therapy monitoring of attention deficit hyperactivity disorder: a new epigenetic biomarker interacting with both genotype and auto-immunity 246
Early alteration of distribution and activity of hippocampal type-1 cannabinoid receptor in Alzheimer's disease-like mice overexpressing the human mutant amyloid precursor protein 188
CSF levels of the endocannabinoid anandamide are reduced in patients with untreated narcolepsy type 1: a pilot study 175
From Traumatic Childhood to Cocaine Abuse: The Critical Function of the Immune System 167
Essential Dietary Bioactive Lipids in Neuroinflammatory Diseases 160
Activity-based protein profiling reveals off-target proteins of the FAAH inhibitor BIA 10-2474 150
Platelet activation: a new vascular activity of anandamide [2] 133
Cannabinoid CB2 receptor ligand profiling reveals biased signalling and off-target activity 124
Development of novel multipotent compounds modulating endocannabinoid and dopaminergic systems 108
Advances in the discovery of fatty acid amide hydrolase inhibitors: what does the future hold? 105
Characterization of Endocannabinoid System and Interleukin Profiles in Ovine AEC: Cannabinoid Receptors Type-1 and Type-2 as Key Effectors of Pro-Inflammatory Response 102
The endocannabinoid hydrolase FAAH is an allosteric enzyme 98
Assay of NAPE-PLD Activity 96
The novel, orally available and peripherally restricted selective cannabinoid CB2 receptor agonist LEI-101 prevents cisplatin-induced nephrotoxicity 91
Lipid Discovery by Combinatorial Screening and Untargeted LC-MS/MS 77
Palmitoylation of cysteine 415 of CB1 receptor affects ligand-stimulated internalization and selective interaction with membrane cholesterol and caveolin 1 75
Plant-Derived and Endogenous Cannabinoids in Epilepsy 72
Biochimica del sangue 37
Bisphenol a deranges the endocannabinoid system of primary sertoli cells with an impact on inhibin b production 36
Endomorphin-1 prevents lipid accumulation via CD36 down-regulation and modulates cytokines release from human lipid-laden macrophages 34
Dynamic changes of anandamide in the cerebrospinal fluid of Parkinson's disease patients 20
Exploring the 1,3-benzoxazine chemotype for cannabinoid receptor 2 as a promising anti-cancer therapeutic 14
Selective Fatty Acid Amide Hydrolase Inhibitors as Potential Novel Antiepileptic Agents 13
In silico and in vitro analysis of major cannabis-derived compounds as fatty acid amide hydrolase inhibitors 12
Endocannabinoids and platelets - Differentiation 9
Chemical Proteomics Reveals Off-Targets of the Anandamide Reuptake Inhibitor WOBE437 8
Endocannabinoids and platelets - Signalling pathways 8
DNA-Protein-Interaction (DPI)-ELISA Assay for PPAR-γ Receptor Binding 8
Effects of Long-Term Oral Administration of N-Palmitoylethanolamine in Subjects with Mild Cognitive Impairment: Study Protocol 4
Conformational Dynamics of Lipoxygenases and Their Interaction with Biological Membranes 4
Totale 22.522
Categoria #
all - tutte 41.305
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 41.305


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20191.230 0 0 0 0 0 0 0 0 0 0 621 609
2019/20206.323 524 509 454 553 469 634 524 578 612 514 479 473
2020/20213.671 419 464 416 459 374 355 443 367 81 91 145 57
2021/2022824 19 91 38 43 19 71 37 33 54 110 82 227
2022/2023981 110 85 20 128 75 238 75 61 93 5 69 22
2023/2024246 30 11 15 15 27 87 8 23 2 3 25 0
Totale 22.522